UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000048538
Receipt number R000055289
Scientific Title Study of isolation culture and functions as transplanted cells in human cardiac stem cells
Date of disclosure of the study information 2022/08/01
Last modified on 2023/05/08 11:49:36

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Study of isolation culture and functions as transplanted cells in human cardiac stem cells

Acronym

Study of isolation culture and functions as transplanted cells in human cardiac stem cells

Scientific Title

Study of isolation culture and functions as transplanted cells in human cardiac stem cells

Scientific Title:Acronym

Study of isolation culture and functions as transplanted cells in human cardiac stem cells

Region

Japan


Condition

Condition

Heart disease

Classification by specialty

Cardiovascular surgery

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To verify whether it is possible to isolate and culture human cardiac stem cells from atrial muscles of patients undergoing heart surgery.

Basic objectives2

Others

Basic objectives -Others

To consider functions as transplanted cells of human cardiac stem cells.

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

To verify whether it is possible to isolate and culture human cardiac stem cells from atrial muscles of patients undergoing heart surgery.

Key secondary outcomes

To consider functions as transplanted cells of human cardiac stem cells.


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1. Patients over the age of 20.
2. Regardless of patient gender.
3. Limited to research for which consent has been obtained from the individual.
4. Patients participating in other clinical studies can also participate in this study.

Key exclusion criteria

1. Patients who are deemed inappropriate as a research subject

Target sample size

20


Research contact person

Name of lead principal investigator

1st name Kimikazu
Middle name
Last name Hamano

Organization

Yamaguchi University

Division name

Department of Surgery and Clinical Science

Zip code

7558505

Address

1-1-1 Minami-kogushi, Yamaguchi, Ube, Japan

TEL

0836-22-2261

Email

cres-sg1@yamaguchi-u.ac.jp


Public contact

Name of contact person

1st name Koji
Middle name
Last name Ueno

Organization

Yamaguchi University

Division name

Department of Surgery and Clinical Science

Zip code

7558505

Address

1-1-1 Minami-kogushi, Yamaguchi, Ube, Japan

TEL

0836-22-2261

Homepage URL


Email

cres-sg1@yamaguchi-u.ac.jp


Sponsor or person

Institute

Yamaguchi University

Institute

Department

Personal name



Funding Source

Organization

Yamaguchi University

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor

Nagasaki University

Name of secondary funder(s)

Nagasaki University


IRB Contact (For public release)

Organization

Yamaguchi University Institutional Review Board

Address

1-1-1 Minami-kogushi, Yamaguchi, Ube, Japan

Tel

0836-22-2428

Email

clin_res@yamaguchi-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2022 Year 08 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2022 Year 07 Month 06 Day

Date of IRB

2022 Year 07 Month 27 Day

Anticipated trial start date

2022 Year 08 Month 01 Day

Last follow-up date

2025 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

age at surgery, gender, NYHAgrade, heart function, high blood pressure, diabetes, history of hyperlipidemia and therapeutic drugs, ANP, BNP, Cr, eGFR, Hb, smoking history, history of coronary artery disease.


Management information

Registered date

2022 Year 08 Month 01 Day

Last modified on

2023 Year 05 Month 08 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000055289


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name